Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Payables (2019 - 2025)

Historic Payables for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $18.4 million.

  • IDEAYA Biosciences' Payables rose 4667.78% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 4667.78%. This contributed to the annual value of $15.4 million for FY2024, which is 13372.23% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Payables stood at $18.4 million, which was up 4667.78% from $17.3 million recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Payables registered a high of $18.4 million during Q3 2025, and its lowest value of $1.3 million during Q1 2021.
  • In the last 5 years, IDEAYA Biosciences' Payables had a median value of $5.2 million in 2023 and averaged $7.8 million.
  • Examining YoY changes over the last 5 years, IDEAYA Biosciences' Payables showed a top increase of 18030.21% in 2025 and a maximum decrease of 871.21% in 2025.
  • Over the past 5 years, IDEAYA Biosciences' Payables (Quarter) stood at $2.1 million in 2021, then skyrocketed by 103.81% to $4.3 million in 2022, then soared by 54.16% to $6.6 million in 2023, then soared by 133.72% to $15.4 million in 2024, then increased by 19.53% to $18.4 million in 2025.
  • Its Payables was $18.4 million in Q3 2025, compared to $17.3 million in Q2 2025 and $17.6 million in Q1 2025.